期刊文献+

不同配比白术茯苓汤对CD大鼠(脾虚型)血清细胞因子水平的影响

Effects of Different Proportions of Atractylodes Macrocephala and Poria Cocos Decoction on Serum Cytokines in Rats With Spleen Deficiency CD
下载PDF
导出
摘要 目的探讨白术茯苓汤不同配比对脾虚型克罗恩病(CD)大鼠血清细胞因子的影响。方法选择96只SPF级SD大鼠,分为A组(脾虚型CD造模)、B组(空白组)。A组按照白术茯苓配比分为模型组、A1、A2、A3、A4、A5、A6、A7、A8、A9、A10。检测血清白介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)水平。结果模型组TNF-α高于B组,IL-10低于B组(P<0.05);A5、A6、A7组TNF-α低于模型组(P<0.05);A6组IL-10升高(P<0.05)。结论脾虚CD大鼠血清细胞因子受白术茯苓汤不同配比影响,特别是A6组。 Objective To investigate the effect of different proportions of atractylodes macrocephala and poria cocos decoction on serum cytokines in rats with spleen deficiency Crohn's disease(CD). Methods 96 SPF grade SD rats were selected and randomly divided into A group(spleen deficiency CD model group) and B group(blank group). The A group was divided into model group, A1, A2, A3, A4, A5, A6, A7, A8, A9 and A10 according to the proportion of atractylodes macrocephala and poria cocos decoction. Serum interleukin-10(IL-10) and tumor necrosis factor alpha(TNF-α) levels were detected. Results TNF-αlevel in model group was higher than B group, IL-10 level was lower than B group(P〈0.05); TNF-αlevel in A5, A6 and A7 group was lower than that of model group(P〈0.05); IL-10 level in A6 group increased(P〈0.05). Conclusion The cytokines in serum of rats with spleen deficiency CD are affected by different proportions of atractylodes macrocephala and poria cocos decoction, especially A6 group.
出处 《中国继续医学教育》 2017年第28期100-101,共2页 China Continuing Medical Education
关键词 脾虚型 克罗恩病 大鼠 白术茯苓汤 细胞因子 spleen deficiency type Crohn's disease rats atractylodes macrocephala and poria cocos decoction cytokines
  • 相关文献

参考文献6

二级参考文献45

  • 1王阶,王永炎,杨戈.中药方剂配伍理论研究方法和模式[J].中国中药杂志,2005,30(1):6-8. 被引量:50
  • 2锁堂,吴焕淦,施达仁.白介素与溃疡性结肠炎[J].世界华人消化杂志,2006,14(4):405-411. 被引量:64
  • 3李乾构,周学文,单兆伟.中华中医药学会内科脾胃病第十四次学术交流会论文汇编[C].山西太原.2002:436-439.
  • 4李乾构,周学文,单兆伟.中华中医药学会内科脾胃病第十四次学术交流会论文汇编[C].2002:264-266,270.
  • 5Morris GP, Beck PL, Herfidge MS, et al. Hapten in- duced model of chronic inflammation and ulceration in the rat colon [J]. Gastroenterology, 1989, 96: 795-803.
  • 6Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities [ J ]. In- flamm Bowel Dis, 2006 (12) : 3-9.
  • 7Neurath M, Finotto S, Fuss I, et al. Regulation of T- cellapoptosis in inflammatory bowel disease: To die or not to die. That is the mucosal question [ J ]. Trends in Ira-munol, 2001, 22 (11): 21-26.
  • 8Braegger CP, Nicholls S, Murch SH, et al. Tumor necrosis factor alpha in stool as a marker of intestinal in- flammation [J]. Lancet, 1992, 339: 89-91.
  • 9Nielsen OH, Vainer B, Madsen SM, et al. Estadb- lished and emerging biological actibity markers of inflam- matory bowel disease [ J ]. Am J Gast roenterol, 2000, 95 : 359-367.
  • 10Akobeng AK, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn' s disease. Cochrane Database Syst Rev [ J ]. 2004, 1 : CD003574.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部